Corrigendum: In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis (Nature Biotechnology (2017) 35 (569-576) DOI: 10.1038/nbt.3836);In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis

Nature Biotechnology

Volumn 35, Issue 6, 2017, Pages 569-576

  Roper, Jatin ^a,b   Tammela, Tuomas ^a   Cetinbas, Naniye Malli ^a   Akkad, Adam ^a   Roghanian, Ali ^a,c   Rickelt, Steffen ^a   Almeqdadi, Mohammad ^a   Wu, Katherine ^a   Oberli, Matthias A ^a   Sánchez Rivera, Francisco ^a   Park, Yoona K ^a   Liang, Xu ^a   Eng, George ^a,d   Taylor, Martin S ^d   Azimi, Roxana ^a   Kedrin, Dmitriy ^a   Neupane, Rachit ^a   Beyaz, Semir ^a   Sicinska, Ewa T ^e   Suarez, Yvelisse ^b   Yoo, James ^b   Chen, Lillian ^b   Zukerberg, Lawrence ^d   Katajisto, Pekka ^f,g   Deshpande, Vikram ^d   Bass, Adam J ^e   Tsichlis, Philip N ^b   Lees, Jacqueline ^a   Langer, Robert ^a   Hynes, Richard O ^a   Chen, Jianzhu ^a   Bhutkar, Arjun ^a   Jacks, Tyler ^a   Yilmaz, Ömer H ^a,d   more..

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f UNIVERSITY OF HELSINKI   (Finland)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLONE CELLS; GENES; MAMMALS; PATHOLOGY; STEM CELLS; TUMORS;

COLORECTAL CANCER; COLORECTAL CANCERS (CRC); EPITHELIAL CELLS; EXPERIMENTAL SYSTEM; SEQUENTIAL ACTIVATION; TUMOR FORMATION; TUMOR PROGRESSIONS; TUMOR SUPPRESSOR GENES;

DISEASES;

AFIMOXIFENE; CRE RECOMBINASE; PHOSPHOGLYCERATE KINASE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLUORESCENCE MICROSCOPY; GENE EDITING; HUMAN; HUMAN CELL; MALE; METASTASIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; TUMOR ENGRAFTMENT; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY; ANIMAL; COLORECTAL TUMOR; DISEASE MODEL; GENETICS; LIVER TUMOR; ORGAN TRANSPLANTATION; PROCEDURES; SECONDARY; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR GENE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EDITING; GENES, NEOPLASM; LIVER NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; ORGAN TRANSPLANTATION;

EID: 85020457568     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1217-1211a     Document Type: Erratum

References (62)

1. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
2. Seshagiri, S., et al. Recurrent R-spondin fusions in colon cancer. Nature 488, 660-664 (2012).
3. Moser, A.R., Pitot, H.C., Dove, W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
4. Su, L.K., et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
5. Roper, J., Hung, K.E. Priceless GEMMs: Genetically engineered mouse models for colorectal cancer drug development. Trends Pharmacol. Sci. 33, 449-455 (2012).
6. Golovko, D., Kedrin, D., Yilmaz, Ö.H., Roper, J. Colorectal cancer models for novel drug discovery. Expert Opin. Drug Discov. 10, 1217-1229 (2015).
7. Hinoi, T., et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 67, 9721-9730 (2007).
8. Haigis, K.M., et al. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat. Genet. 40, 600-608 (2008).
9. Xue, Y., Johnson, R., Desmet, M., Snyder, P.W., Fleet, J.C. Generation of a transgenic mouse for colorectal cancer research with intestinal cre expression limited to the large intestine. Mol. Cancer Res. MCR 8, 1095-1104 (2010).
10. Shibata, H., et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278, 120-123 (1997).
11. Hung, K.E., et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc. Natl. Acad. Sci. USA 107, 1565-1570 (2010).
12. Hadac, J.N., et al. Colon tumors with the simultaneous induction of driver mutations in APC, KRAS, PIK3CA still progress through the adenoma-to-carcinoma sequence. Cancer Prev. Res. (Phila.) 8, 952-961 (2015).
13. Fu, X.Y., Besterman, J.M., Monosov, A., Hoffman, R.M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA 88, 9345-9349 (1991).
14. Takahashi, T., Morotomi, M., Nomoto, K. A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells. Cancer Sci. 95, 514-519 (2004).
15. Martin, E.S., et al. Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation. Clin. Cancer Res. 19, 2929-2940 (2013).
16. Bhullar, J.S., et al. A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation. J. Am. Coll. Surg. 213, 54-60, discussion 60-61 (2011).
17. Zigmond, E., et al. Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PLoS One 6, e28858 (2011).
18. Sánchez-Rivera, F.J., Jacks, T. Applications of the CRISPR-Cas9 system in cancer biology. Nat. Rev. Cancer 15, 387-395 (2015).
19. Sánchez-Rivera, F.J., et al. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516, 428-431 (2014).
20. Maddalo, D., Ventura, A. Somatic engineering of oncogenic chromosomal rearrangements: A perspective. Cancer Res. 76, 4918-4923 (2016).
21. Drost, J., et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43-47 (2015).
22. Matano, M., et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21, 256-262. doi:10.1038/nm.3802 (2015).
23. Beyaz, S., et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53-58 (2016).
24. Pinto, D., Robine, S., Jaisser, F., El Marjou, F.E., Louvard, D. Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J. Biol. Chem. 274, 6476-6482 (1999).
25. Barker, N., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
26. Schepers, A.G., et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730-735 (2012).
27. Barker, N., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
28. Schwank, G., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13, 653-658 (2013).
29. Heckl, D., et al. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat. Biotechnol. 32, 941-946 (2014).
30. McKenna, A., et al. Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science 353, aaf7907 (2016).
31. Platt, R.J., et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440-455 (2014).
32. Yui, S., et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nat. Med. 18, 618-623 (2012).
33. Fukuda, M., et al. Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon. Genes Dev. 28, 1752-1757 (2014).
34. O'Rourke, K.P., et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat. Biotechnol. doi:10.1038/nbt.3837 (2017).
35. Le, D.T., et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509-2520 (2015).
36. Li, Y., et al. Induction of functional human macrophages from bone marrow promonocytes by M-CSF in humanized mice. J. Immunol. 191, 3192-3199 (2013).
37. Sharpless, N.E., Depinho, R.A. The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 5, 741-754 (2006).
38. Roper, J., et al. Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer. Cancer Lett. 347, 204-211 (2014).
39. van de Wetering, M., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933-945 (2015).
40. Fujii, M., et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827-838 (2016).
41. Kuraguchi, M., et al. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet. 2, e146 (2006).
42. Johnson, L., et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
43. el Marjou, F., et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186-193 (2004).
44. Huch, M., et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247-250 (2013).
45. Madisen, L., et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133-140 (2010).
46. Shultz, L.D., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477-6489 (2005).
47. Akama-Garren, E.H., et al. A modular assembly platform for rapid generation of DNA constructs. Sci. Rep. 6, 16836 (2016).
48. Malina, A., et al. Repurposing CRISPR/Cas9 for in situ functional assays. Genes Dev. 27, 2602-2614 (2013).
49. Vidigal, J.A., Ventura, A. Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries. Nat. Commun. 6, 8083 (2015).
50. Miyoshi, H., Stappenbeck, T.S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8, 2471-2482 (2013).
51. Koo, B.-K., Sasselli, V., Clevers, H. Retroviral gene expression control in primary organoid cultures. Curr. Protoc. Stem Cell Biol. 27, 5-6 (2013).
52. Roper, J., et al. The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer. PLoS One 6, e25132 (2011).
53. Yilmaz, Ö.H., et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486, 490-495 (2012).
54. Tammela, T., et al. Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105, 4642-4648 (2005).
55. Chen, D., et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948-6951 (2012).
56. Dong, Y., et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl. Acad. Sci. USA 111, 3955-3960 (2014).
57. Abouelhoda, M.I., Kurtz, S., Ohlebusch, E. Replacing suffix trees with enhanced suffix arrays. J. Discrete Algorithms 2, 53-86 (2004).
58. Smith, T.F., Waterman, M.S. Identification of common molecular subsequences. J. Mol. Biol. 147, 195-197 (1981).
59. Wang, K., Li, M., Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
60. Döring, A., Weese, D., Rausch, T., Reinert, K. SeqAn an efficient, generic C++ library for sequence analysis. BMC Bioinformatics 9, 11 (2008).
61. Zhao, M., Lee, W.-P., Garrison, E.P., Marth, G.T. SSW library: An SIMD Smith-Waterman C/C. library for use in genomic applications. PLoS One 8, e82138 (2013).
62. Thorvaldsdóttir, H., Robinson, J.T., Mesirov, J.P. Integrative Genomics Viewer (IGV): High-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178-192 (2013).